isoindolinones including indoprofen and DWP205190 drugs from 2-alkylbenzamide substrates by transition metal-free intramolecular selective oxidativecoupling of C(sp(3))-H and N-H bonds utilizing iodine, potassium carbonate and di-tert-butyl peroxide in acetonitrile at 110-140 degrees C.
[EN] 3-CYCLOPENTYLOXY-4-METHOXYPHENYL-ISOINDOLINONE DERIVATIVES AND THE USE THEREOF<br/>[FR] DERIVES 3-CYCLOPENTYLOXY-4-METHOXYPHENYL-ISOINDOLINONE ET UTILISATION
申请人:DAE WOONG PHARMA
公开号:WO2002081446A1
公开(公告)日:2002-10-17
This invention relates to novel compounds of 3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives having the activity to inhibit tumor necrosis factor-α (TNF-α) or cyclic AMP phosphodiesterase IV (PDE 4). In more detail, this invention is directed to the preparation processes of the novel compounds of formula [1], and a pharmaceutically acceptable salt thereof, and pharmaceutical compositions possessing important biological therapeutic effect on inflammatory and autoimmune diseases associated with a detrimental excess of TNF-α.